Electronic Decision Aid for Atrial Fibrillation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new electronic tool designed to assist individuals with atrial fibrillation—a condition where the heart beats irregularly—in choosing the best stroke prevention treatment. Researchers aim to determine if this electronic patient decision aid enhances treatment decisions made by patients and doctors compared to standard educational materials. Individuals diagnosed with atrial fibrillation within the past year and who have an upcoming specialist visit may find this trial suitable. Participants will either use the decision aid alongside standard information or receive only the standard information before their appointment. As an unphased trial, this study provides a unique opportunity to contribute to research that could improve decision-making tools for future patients.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop your current medications. However, if you are currently on dual antiplatelet therapy for a reason other than atrial fibrillation, you cannot participate.
What prior data suggests that this electronic patient decision aid is safe for use in stroke prevention therapy decision-making?
Research has shown that digital tools, like the electronic patient decision aid in this trial, are generally safe. These tools assist patients and doctors in making better health decisions together. Studies have found that these aids can reduce "decisional conflict," helping people feel more confident and clear about their health choices. Some evidence suggests they can improve knowledge, although this is less certain.
Past studies have not linked electronic decision aids to any safety issues. They primarily provide information rather than function as treatments like medicines or surgeries, making them very low risk. Essentially, these tools aim to support better discussions and decisions during medical visits without causing harm.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new way to empower patients with atrial fibrillation. Unlike traditional treatments that primarily focus on medication management and procedures, like anticoagulants or catheter ablation, this electronic decision aid provides patients with tailored information and tools to make informed decisions about their treatment options. This approach emphasizes patient engagement and shared decision-making, which could lead to better adherence to treatment plans and improved health outcomes. By integrating technology into patient education, the trial aims to enhance patients' understanding and involvement in their own care, which is a promising step forward in managing atrial fibrillation.
What evidence suggests that this electronic patient decision aid is effective for atrial fibrillation?
Research has shown that digital tools can boost patients' confidence in making health decisions. While these tools might also enhance patient knowledge, this remains less certain. In this trial, participants will receive either web-based information alone or web-based information with access to a patient decision aid. Studies have found that patient decision aids can enhance shared decision-making, enabling patients and doctors to collaborate on selecting the best treatment. For patients with atrial fibrillation, these aids could help them better understand stroke prevention options and make more informed choices.14678
Who Is on the Research Team?
Stephen B Wilton, MD
Principal Investigator
University of Calgary
Are You a Good Fit for This Trial?
This trial is for adults over 18 who were diagnosed with non-valvular atrial fibrillation within the last year. They can have any level of stroke risk and either be new to oral anticoagulant therapy or treated for less than three months. Participants must have a specialist visit scheduled within the next 7-30 days.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive either the RAPID AFib decision aid or standard educational materials before their clinic visit
Clinic Visit
Participants attend a clinic visit where shared decision-making is assessed
Follow-up
Study participation ends after completion of a post-visit survey to assess shared decision-making and therapy decisions
What Are the Treatments Tested in This Trial?
Interventions
- Electronic patient decision aid
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Servier
Industry Sponsor